259 related articles for article (PubMed ID: 36310879)
1.
Yang C; Huang Y; Zhou Y; Zang X; Deng H; Liu Y; Shen D; Xue X
Front Cell Infect Microbiol; 2022; 12():1041036. PubMed ID: 36310879
[No Abstract] [Full Text] [Related]
2. The primary target organ of Cryptococcus gattii is different from that of Cryptococcus neoformans in a murine model.
Ngamskulrungroj P; Chang Y; Sionov E; Kwon-Chung KJ
mBio; 2012; 3(3):. PubMed ID: 22570277
[TBL] [Abstract][Full Text] [Related]
3. Contribution of Laccase Expression to Immune Response against Cryptococcus gattii Infection.
Hansakon A; Ngamskulrungroj P; Angkasekwinai P
Infect Immun; 2020 Feb; 88(3):. PubMed ID: 31871099
[TBL] [Abstract][Full Text] [Related]
4. Cryptococcus gattii polysaccharide capsule: An insight on fungal-host interactions and vaccine studies.
Freitas GJC; Santos DA
Eur J Immunol; 2021 Sep; 51(9):2206-2209. PubMed ID: 34396521
[TBL] [Abstract][Full Text] [Related]
5. Dectin-3 Recognizes Glucuronoxylomannan of
Huang HR; Li F; Han H; Xu X; Li N; Wang S; Xu JF; Jia XM
Front Immunol; 2018; 9():1781. PubMed ID: 30131805
[No Abstract] [Full Text] [Related]
6. Interferon-γ promotes phagocytosis of Cryptococcus neoformans but not Cryptococcus gattii by murine macrophages.
Ikeda-Dantsuji Y; Ohno H; Tanabe K; Umeyama T; Ueno K; Nagi M; Yamagoe S; Kinjo Y; Miyazaki Y
J Infect Chemother; 2015 Dec; 21(12):831-6. PubMed ID: 26477011
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary Iron Limitation Induced by Exogenous Type I IFN Protects Mice from Cryptococcus gattii Independently of T Cells.
Davis MJ; Moyer S; Hoke ES; Sionov E; Mayer-Barber KD; Barber DL; Cai H; Jenkins L; Walter PJ; Chang YC; Kwon-Chung KJ
mBio; 2019 Jun; 10(3):. PubMed ID: 31213551
[No Abstract] [Full Text] [Related]
8. Evasion of Innate Immune Responses by the Highly Virulent Cryptococcus gattii by Altering Capsule Glucuronoxylomannan Structure.
Urai M; Kaneko Y; Ueno K; Okubo Y; Aizawa T; Fukazawa H; Sugita T; Ohno H; Shibuya K; Kinjo Y; Miyazaki Y
Front Cell Infect Microbiol; 2015; 5():101. PubMed ID: 26779451
[TBL] [Abstract][Full Text] [Related]
9. Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Thailand display diverse phenotypic interactions with macrophages.
Hansakon A; Mutthakalin P; Ngamskulrungroj P; Chayakulkeeree M; Angkasekwinai P
Virulence; 2019 Dec; 10(1):26-36. PubMed ID: 30520685
[TBL] [Abstract][Full Text] [Related]
10. Innate host defenses against Cryptococcus neoformans.
Hole C; Wormley FL
J Microbiol; 2016 Mar; 54(3):202-11. PubMed ID: 26920880
[TBL] [Abstract][Full Text] [Related]
11. Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil.
Grizante Barião PH; Tonani L; Cocio TA; Martinez R; Nascimento É; von Zeska Kress MR
Mycoses; 2020 Dec; 63(12):1341-1351. PubMed ID: 32869413
[TBL] [Abstract][Full Text] [Related]
12. Clinical and microbiological characteristics of cryptococcosis in Singapore: predominance of Cryptococcus neoformans compared with Cryptococcus gattii.
Chan M; Lye D; Win MK; Chow A; Barkham T
Int J Infect Dis; 2014 Sep; 26():110-5. PubMed ID: 25018090
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of IFN-γ secretion after stimulation with C. neoformans and C. gattii antigens in individuals with frequent exposure to the fungus.
Maciel IF; de Freitas-Xavier RS; Vicentini AP; Apoliano CF; Ruiz Fernandes J; Dias ADS; Gimenes VFM; Benard G; Vasconcelos DM
J Mycol Med; 2022 May; 32(2):101230. PubMed ID: 34923245
[TBL] [Abstract][Full Text] [Related]
14. Etiological factors of cryptococcosis - what makes them pathogens ?
Dylag M
Med Dosw Mikrobiol; 2015; 67(3-4):221-31. PubMed ID: 27019916
[TBL] [Abstract][Full Text] [Related]
15. Infective capacity of Cryptococcus neoformans and Cryptococcus gattii in a human astrocytoma cell line.
Olave MC; Vargas-Zambrano JC; Celis AM; Castañeda E; González JM
Mycoses; 2017 Jul; 60(7):447-453. PubMed ID: 28338245
[TBL] [Abstract][Full Text] [Related]
16. In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India.
Chowdhary A; Randhawa HS; Sundar G; Kathuria S; Prakash A; Khan Z; Sun S; Xu J
J Med Microbiol; 2011 Jul; 60(Pt 7):961-967. PubMed ID: 21393452
[TBL] [Abstract][Full Text] [Related]
17. Cryptococcus gattii induces a cytokine pattern that is distinct from other cryptococcal species.
Schoffelen T; Illnait-Zaragozi MT; Joosten LA; Netea MG; Boekhout T; Meis JF; Sprong T
PLoS One; 2013; 8(1):e55579. PubMed ID: 23383232
[TBL] [Abstract][Full Text] [Related]
18. High-resolution melting analysis for identification of the Cryptococcus neoformans-Cryptococcus gattii complex.
Gago S; Zaragoza Ó; Cuesta I; Rodríguez-Tudela JL; Cuenca-Estrella M; Buitrago MJ
J Clin Microbiol; 2011 Oct; 49(10):3663-6. PubMed ID: 21832024
[TBL] [Abstract][Full Text] [Related]
19. Cryptococcus neoformans and Cryptococcus gattii genes preferentially expressed during rat macrophage infection.
Goulart L; Rosa e Silva LK; Chiapello L; Silveira C; Crestani J; Masih D; Vainstein MH
Med Mycol; 2010 Nov; 48(7):932-41. PubMed ID: 20302549
[TBL] [Abstract][Full Text] [Related]
20. Environmental prevalence of Cryptococcus neoformans and Cryptococcus gattii in India: an update.
Chowdhary A; Rhandhawa HS; Prakash A; Meis JF
Crit Rev Microbiol; 2012 Feb; 38(1):1-16. PubMed ID: 22133016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
